動物疼痛管理的全球市場 (2020-2027年)

全球動物疼痛管理的市場規模，預計從2020年到2027年的預測期間內以5.10％的年複合成長率成長。

動物的疼痛伴隨的發炎性疾病的盛行率的上升，動物擁有的增加，動物醫療保健的支出上升，對動物健康的意識高漲，及動物服務的增加，是推動全球動物疼痛管理市場的主要原因。

動物用醫藥品的使用相關動物的副作用，在預測期間內有抑制市場的可能性。

本報告提供全球動物疼痛管理市場相關調查，市場概要，各市場區隔及各地區的市場分析與預測，競爭情形分析，並提供主要企業簡介等資訊。

目錄

第1章 全球動物疼痛管理市場:調查手法、範圍

• 調查手法
• 調查範圍

第2章 全球動物疼痛管理市場:主要趨勢、發展

• 主要的趨勢與發展

第3章 全球動物疼痛管理市場:產業分析

• 產業的影響要素(促進因素與阻礙因素)
• 競爭力:波特的五力分析
• 法規分析

第4章 全球動物疼痛管理市場:各產品

• 醫藥品
  • NSAID
  • 類鴉片物質
• 各設備
  • 雷射治療
  • 電磁氣療法
• 各應用領域
  • 骨關節炎
  • 癌症
  • 手術後疼痛
  • 關節痛

第5章 全球動物疼痛管理市場:各動物類型

• 伴同性
• 家畜

第6章 全球動物疼痛管理市場:各地區

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 南美
  • 巴西
  • 阿根廷
  • 其他南美
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他的歐洲
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他的亞太地區
• 其他地區

第7章 全球動物疼痛管理市場:競爭情形

• 市場參與企業分析
• 廠商採用的主要策略
• 產品的基準

第8章 全球動物疼痛管理市場:企業簡介

• Assisi Animal Health
• Boehringer Ingelheim
• Ceva
• Chanelle Veterinary Limited
• Dechra Pharmaceuticals Plc
• Elanco
• Intervet Inc.
• Norbrook
• Vetoquinol S.A.
• Zoetis

第9章 全球獸醫疼痛管理市場:附錄

Market Overview

The Global Veterinary Pain Management Market is expected to grow at a CAGR of 5.10% during the forecast period 2020-2027.

Veterinary Pain Management refers to the medical services for the prevention, diagnosis, and treatment of diseases like Osteoarthritis, Postoperative pain, and Cancer in companion and livestock animals.

Drivers and Restraints

The rising prevalence of painful and inflammatory diseases in animals, increasing animal ownership, rising expenditure for animal healthcare, growing awareness about animal health and increase in veterinary services are the primary factors driving the Veterinary Pain Management Market globally.

Diseases like cancer and osteoarthritis are rapidly increasing in animals. There are about 65 million dogs and 32 million cats in the United States. According to the Animal Cancer Foundation, each year, approximately 6 million dogs were diagnosed with cancer similar number of cats were along diagnosed with cancer in the U.S. According to The Veterinary Cancer Society, disease is a leading cause of death in 47% of dogs, especially dogs over age ten, and 32% of cats. Thus, the rising trend of cancer in cats and dogs in the U.S. will propel the market for Veterinary Pain Management.

The side-effects like vomiting, diarrhea, stomach ulcers, skin irritation, depression and restlessness associated with the use of Veterinary drugs is making the animal owners reluctant in putting their pets under medication. Therefore, the side-effects in animals about the use of veterinary drugs can restrain the market during the forecast period.

Market Segmentation

The Global Veterinary Pain Management Market segmented by product, application and animal type. Product type segment includes Drugs and Device.

The drugs segment can further be segmented as Opioids and NSAIDs. Device segment also consists of Laser Therapy and Electromagnetic Therapy.

Further, the application segment comprises of Osteoarthritis, Cancer, Postoperative Pain and Joint Pain.

Based on the animal type the market can be segmented as Livestock and Companion Animal. The companion animal segment accounts for the broader market share.

It can be attributed to the increasing companion animal ownership, growing awareness regarding pet health among pet owners and rising pet healthcare expenditure. In U.K., the Pet owners spend most on Veterinary Services for their pets after Pet food; this trend will propel the market for Veterinary pain management in U.K. in the nearby future.

Geographical Share

The report segments the market by geography which includes North America, South America, Europe, Asia-Pacific and Rest of the World.

North America is the most dominant region for Veterinary Pain Management Market owing to the high number of animal adoptions, increasing animal healthcare expenditure and growing veterinary practices.

The rising prevalence of chronic diseases such as osteoarthritis and cancer is also contributing to the growth of the Veterinary Pain Management Market in this region.

Asia-Pacific is estimated to be the fastest growing region during the forecast period due to the large livestock population in countries such as China and India. According to the Indian Ministry of Agriculture, the livestock population in India was around 512 million in 2012.

Thus the large livestock population and rising incidents of joint pain, osteoarthritis and cancer in the APAC region will boost the market for veterinary pain services in the coming years.

Industry Competition in Veterinary Pain Management Market

Some of the key players in the Global Veterinary Pain Management market are Assisi Animal Health, Boehringer Ingelheim, Ceva, Chanelle Veterinary Limited, Dechra Pharmaceuticals Plc, Elanco, Intervet Inc., Northbrook, Vetoquinol S.A., and Zoetis.

Key market segments covered

By Product

Drugs

Therapy

By Application

Osteoarthritis

Cancer

Postoperative Pain

Joint Pain

By Animal Type

Companion

Livestock

By Region

Asia Pacific

Europe

North America

South America

Rest of the World

Why purchase the report?

Visualize the composition of the Veterinary Pain Management market across each indication, regarding type and application highlighting the critical commercial assets and players.

Identify business opportunities in Veterinary Pain Management market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the Veterinary Pain Management market level 4/5 segmentation

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study

Product mapping in excel for the key Veterinary Pain Management market products of all major market players.

Target Audience

Raw Material Suppliers/ Buyers

Product Suppliers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Global Veterinary Pain Management Market - Methodology and Scope

• 1.1. Research Methodology
• 1.2. The scope of the Report

2. Global Veterinary Pain Management Market - Trends

• 2.1. Key Trends & Developments

3. Global Veterinary Pain Management Market - Industry Analysis

• 3.1. Industry Impact Factors (Drivers & Restraints)
• 3.2. Competitive Intensity- Porter 5 Forces
• 3.3. Regulatory Analysis

4. Global Veterinary Pain Management Market - By Product

• 4.1. Drugs
  • 4.1.1. NSAIDs
  • 4.1.2. Opioids
• 4.2. By Device
  • 4.2.1. Laser Therapy
  • 4.2.2. Electromagnetic Therapy
• 4.3. By Application
  • 4.3.1. Osteoarthritis
  • 4.3.2. Cancer
  • 4.3.3. Postoperative Pain
  • 4.3.4. Joint Pain

5. Global Veterinary Pain Management Market - By Animal Type

• 5.1. Companion
• 5.2. Livestock

6. Global Veterinary Pain Management Market - By Geography

• 6.1. North America
  • 6.1.1. The United States
  • 6.1.2. Canada
  • 6.1.3. Mexico
• 6.2. South America
  • 6.2.1. Brazil
  • 6.2.2. Argentina
  • 6.2.3. Rest of South America
• 6.3. Europe
  • 6.3.1. Germany
  • 6.3.2. United Kingdom
  • 6.3.3. France
  • 6.3.4. Rest of Europe
• 6.4. Asia-Pacific
  • 6.4.1. China
  • 6.4.2. Japan
  • 6.4.3. India
  • 6.4.4. Rest of Asia-Pacific
• 6.5. Rest of the World

7. Global Veterinary Pain Management Market - Competitive Landscape

• 7.1. Market Player Analysis
• 7.2. Key Strategies adopted by Manufacturers
• 7.3. Product Benchmarking

8. Global Veterinary Pain Management Market - Company Profiles

• 8.1. Assisi Animal Health
• 8.2. Boehringer Ingelheim
• 8.3. Ceva
• 8.4. Chanelle Veterinary Limited
• 8.5. Dechra Pharmaceuticals Plc
• 8.6. Elanco
• 8.7. Intervet Inc.
• 8.8. Norbrook
• 8.9. Vetoquinol S.A.
• 8.10. Zoetis

9. Global Veterinary Pain Management Market - Appendix

• 9.1. Sources
• 9.2. List of Tables
• 9.3. Expert Panel Validation
• 9.4. Disclaimer
• 9.5. Contact Us